6-Phosphogluconic acid
|
Basic information |
| Metabolite name | 6-Phosphogluconic acid |
 | HMDB0001316 |
 |
C00345 |
 |
91493 |
| Synonyms | 6-Phospho-D-gluconate |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | 6-Phosphogluconic acid |
| HMDB0001316 |
|
C00345 |
|
91493 |
| Synonyms | 6-Phospho-D-gluconate |
| No. of studies | 6 |
|
Relationship between 6-Phosphogluconic acid and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 14h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M1091 | Type1 | CMS vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M1092 | Type1 | CMS group vs. control group | Ventral hippocampus | Wistar rat | Up |
| Study M181 | Type3 | venlafaxine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M663 | Type3 | diterpene ginkgolides group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M858 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |